StockWatch
·
Pharmacy Retail
Legal5 Jun 2026, 06:05 pm

Medplus Subsidiary Faces 15-Day Drug License Suspension

AI Summary

Medplus Health Services Ltd's subsidiary, Optival Health Solutions Private Limited, has received a 15-day suspension order for a drug license for a store located in Ongole, Andhra Pradesh. The suspension, effective from June 4, 2026, is due to alleged violations under Rule 65 of the Drugs and Cosmetics Act, 1940. The company estimates a potential revenue loss of approximately ₹1.50 lacs as a result of this action. The details of the suspension will be made available on the company's website and stock exchange portals.

Key Highlights

  • Subsidiary's drug license suspended for 15 days.
  • Action taken by Andhra Pradesh Drugs Control Administration.
  • Potential revenue loss estimated at ₹1.50 lacs.
  • Violation cited under Drugs and Cosmetics Act.